"
Team:Paris Bettencourt
From 2013.igem.org
| Line 187: | Line 187: | ||
.subpanel8 img:hover { | .subpanel8 img:hover { | ||
background:rgb(252,250,229); | background:rgb(252,250,229); | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
} | } | ||
</style> | </style> | ||
| Line 220: | Line 201: | ||
<div id="page"> | <div id="page"> | ||
<div id="panel10"> | <div id="panel10"> | ||
| - | |||
</div> | </div> | ||
<div class="panel"> | <div class="panel"> | ||
| Line 230: | Line 210: | ||
<div class="cont"> | <div class="cont"> | ||
<p style="font-size:28px;"> | <p style="font-size:28px;"> | ||
| - | Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB. | + | Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB. These range from detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins. |
</p> | </p> | ||
</div> | </div> | ||
| Line 253: | Line 233: | ||
</div> | </div> | ||
</div> | </div> | ||
| + | <div class="cont"> | ||
| + | <p style="font-size:28px;"> | ||
| + | Clink in this box to see the overview! | ||
| + | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Revision as of 03:26, 5 October 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB. These range from detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
Infiltrate macrophages with an E.coli producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.
Clink in this box to see the overview!
Results page
+33 1 44 41 25 22/25
team2013@igem-paris.org 
